{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:32:23Z","timestamp":1790299943688,"version":"4.1.0"},"reference-count":95,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Carnitine palmitoyltransferase (CPT) catalyzes the transfer of long- and medium-chain fatty acids from cytoplasm into mitochondria, where oxidation of fatty acids takes place. Deficiency of CPT enzyme is associated with rare diseases of fatty acid metabolism. CPT is present in two subforms: CPT I at the outer mitochondrial membrane and carnitine palmitoyltransferase II (CPT II) inside the mitochondria. Deficiency of CPT II results in the most common inherited disorder of long-chain fatty acid oxidation affecting skeletal muscle. There is a lethal neonatal form, a severe infantile hepato-cardio-muscular form, and a rather mild myopathic form characterized by exercise-induced myalgia, weakness, and myoglobinuria. Total CPT activity (CPT I + CPT II) in muscles of CPT II-deficient patients is generally normal. Nevertheless, in some patients, not detectable to reduced total activities are also reported. CPT II protein is also shown in normal concentration in patients with normal CPT enzymatic activity. However, residual CPT II shows abnormal inhibition sensitivity towards malonyl-CoA, Triton X-100 and fatty acid metabolites in patients. Genetic studies have identified a common p.Ser113Leu mutation in the muscle form along with around 100 different rare mutations. The biochemical consequences of these mutations have been controversial. Hypotheses include lack of enzymatically active protein, partial enzyme deficiency and abnormally regulated enzyme. The recombinant enzyme experiments that we recently conducted have shown that CPT II enzyme is extremely thermoliable and is abnormally inhibited by different emulsifiers and detergents such as malonyl-CoA, palmitoyl-CoA, palmitoylcarnitine, Tween 20 and Triton X-100. Here, we present a conceptual overview on CPT II deficiency based on our own findings and on results from other studies addressing clinical, biochemical, histological, immunohistological and genetic aspects, as well as recent advancements in diagnosis and therapeutic strategies in this disorder.<\/jats:p>","DOI":"10.3390\/molecules25081784","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T03:10:01Z","timestamp":1586833801000},"page":"1784","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach"],"prefix":"10.3390","volume":"25","author":[{"given":"Pushpa Raj","family":"Joshi","sequence":"first","affiliation":[{"name":"Department of Neurology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube Str. 40, 06120 Halle (Saale), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Zierz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube Str. 40, 06120 Halle (Saale), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1203\/00006450-199005000-00016","article-title":"Immunoquantitative analysis of human carnitine palmitoyltransferase I and II defects","volume":"27","author":"Demaugre","year":"1990","journal-title":"Pediatr. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0024-3205(91)90560-X","article-title":"Interaction of receptors for prostaglandin E1\/prostacyclin and insulin in human erythrocytes and platelets","volume":"49","author":"Kahn","year":"1991","journal-title":"Life Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0952-3278(94)90054-X","article-title":"Insulin mediated processes in platelets, erythrocytes and monocytes\/macrophages: Effects of essential fatty acid metabolism","volume":"51","year":"1994","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0304-4157(84)90005-4","article-title":"The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function","volume":"779","author":"Stubbs","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1038\/sj.ejcn.1600745","article-title":"Essential fatty acids as determinants of lipid requirements in infants, children and adults","volume":"53","author":"Uauy","year":"1999","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.bi.49.070180.002143","article-title":"Regulation of hepatic fatty acid oxidation and ketone body production","volume":"49","author":"McGarry","year":"1980","journal-title":"Annu. Rev. Biochem."},{"key":"ref_7","first-page":"2297","article-title":"Mitochondrial fatty acid oxidation disorders","volume":"Volume 8","author":"Scriver","year":"2001","journal-title":"The Metabolic and Molecular Bases of Inherited Disease"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1016\/S0021-9258(19)43841-6","article-title":"The localization of carnitine palmitoyltransferase on the inner membrane of bovine liver mitochondria","volume":"248","author":"Brosnan","year":"1973","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","article-title":"The Mitochondrial Carnitine Palmitoyltransferase System\u2014From Concept to Molecular Analysis","volume":"244","author":"McGarry","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1042\/bj3230711","article-title":"Topology of carnitine palmitoyltransferase I in the mitochondrial outer membrane","volume":"323","author":"Fraser","year":"1997","journal-title":"Biochem. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1042\/bj20031373","article-title":"Structural model of carnitine palmitoyltransferase I based on the carnitine acetyltransferase crystal","volume":"379","author":"Morillas","year":"2004","journal-title":"Biochem. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj3200345","article-title":"Mammalian mitochondrial beta-oxidation","volume":"320","author":"Eaton","year":"1996","journal-title":"Biochem. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11010-014-2098-z","article-title":"Carnitine\/acylcarnitine translocase and carnitine palmitoyltransferase 2 form a complex in the inner mitochondrial membrane","volume":"394","author":"Console","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"25655","DOI":"10.1074\/jbc.M111.228692","article-title":"Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex","volume":"286","author":"Lee","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00044-5","article-title":"Fatty acid import into mitochondria","volume":"1486","author":"Kerner","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1067\/mpd.2002.128545","article-title":"Lethal neonatal and severe late infantile forms of carnitine palmitoyltransferase II deficiency associated with compound heterozygosity for different protein truncation mutations","volume":"141","author":"Vladutiu","year":"2002","journal-title":"J. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/01.LAB.0000098428.51765.83","article-title":"Carnitine palmitoyltransferase II deficiency: A clinical, biochemical, and molecular review","volume":"83","author":"Sigauke","year":"2003","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/000992289903800102","article-title":"Fatal carnitine palmitoyltransferase II deficiency in a newborn: New phenotypic features","volume":"38","author":"Pierce","year":"1999","journal-title":"Clin. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/cge.12593","article-title":"Diagnostic pitfall in antenatal manifestations of CPT II deficiency","volume":"89","author":"Boemer","year":"2016","journal-title":"Clin. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0960-8966(99)00096-6","article-title":"Genotype\/phenotype correlation in carnitine palmitoyl transferase II deficiency: Lessons from a compound heterozygous patient","volume":"10","author":"Thuillier","year":"2000","journal-title":"Neuromuscul. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ymgme.2006.08.004","article-title":"Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency","volume":"89","author":"Isackson","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1440-1827.2008.02250.x","article-title":"Autopsy case of the neonatal form of carnitine palmitoyltransferase-II deficiency triggered by a novel disease-causing mutation del1737C","volume":"58","author":"Semba","year":"2008","journal-title":"Pathol. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s100380300001","article-title":"A novel splice site mutation in neonatal carnitine palmitoyl transferase II deficiency","volume":"48","author":"Smeets","year":"2003","journal-title":"J. Hum. Genet."},{"key":"ref_24","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (1993). Carnitine Palmitoyltransferase II Deficiency. GeneReviews\u00ae, University of Washington."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI115090","article-title":"Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies","volume":"87","author":"Demaugre","year":"1991","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ymgme.2011.05.003","article-title":"Neonatal carnitine palmitoyltransferase II deficiency associated with Dandy-Walker syndrome and sudden death","volume":"104","author":"Yahyaoui","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00431-010-1261-0","article-title":"Post-mortem MRI reveals CPT2 deficiency after sudden infant death","volume":"169","author":"Bouchireb","year":"2010","journal-title":"Eur. J. Pediatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/mus.10217","article-title":"Phenotypic variability among first-degree relatives with carnitine palmitoyltransferase II deficiency","volume":"26","author":"Vladutiu","year":"2002","journal-title":"Muscle Nerve"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2013.12.026","article-title":"Carnitine palmitoyltransferase II (CPT II) deficiency: Genotype-phenotype analysis of 50 patients","volume":"338","author":"Joshi","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.182.4115.929","article-title":"Muscle Carnitine Palmityltransferase Deficiency and Myoglobinuria","volume":"182","author":"DiMauro","year":"1973","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2007.09.015","article-title":"Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency","volume":"266","author":"Corti","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.62.1.37","article-title":"Muscle Carnitine Palmitoyltransferase II Deficiency: Clinical and Molecular Genetic Features and Diagnostic Aspects","volume":"62","author":"Deschauer","year":"2005","journal-title":"Arch. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jocn.2018.11.023","article-title":"Phenotype of carnitine palmitoyltransferase II (CPT II) deficiency: A questionnaire-based survey","volume":"59","author":"Joshi","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/j.ajkd.2004.12.006","article-title":"Carnitine palmitoyltransferase II deficiency due to a novel gene variant in a patient with rhabdomyolysis and ARF","volume":"45","author":"Kaneoka","year":"2005","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/mgme.1999.2938","article-title":"Carnitine Palmitoyltransferase Deficiencies","volume":"68","author":"Bonnefont","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1023\/A:1005655927639","article-title":"Adult carnitine palmitoyltransferase II deficiency: Detection of characteristic carnitine esters in serum by tandem mass spectrometry","volume":"22","author":"Gempel","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s004310100802","article-title":"\u201cAdult\u201d form of muscular carnitine palmitoyltransferase II deficiency: Manifestation in a 2-year-old child","volume":"160","author":"Gempel","year":"2001","journal-title":"Eur. J. Pediatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0887-8994(99)00125-3","article-title":"Muscular carnitine palmitoyltransferase II deficiency in infancy","volume":"22","author":"Hurvitz","year":"2000","journal-title":"Pediatr. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-0004.2011.01786.x","article-title":"Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency","volume":"82","author":"Fanin","year":"2012","journal-title":"Clin. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1179\/016164110X12767786356390","article-title":"Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency","volume":"33","author":"Anichini","year":"2011","journal-title":"Neurol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0022-3476(88)80180-X","article-title":"Mutant carnitine palmitoyltransferase associated with myoadenylate deaminase deficiency in skeletal muscle","volume":"112","author":"Reuschenbach","year":"1988","journal-title":"J. Pediatr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.20320","article-title":"Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations: CPT2 Gene Mutations and Fuel Use","volume":"57","author":"Ejstrup","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<941::AID-MUS20>3.0.CO;2-Z","article-title":"Molecular analysis in Spanish patients with muscle carnitine palmitoyltransferase deficiency","volume":"22","author":"Rubio","year":"1999","journal-title":"Muscle Nerve"},{"key":"ref_44","first-page":"1697","article-title":"Carnitine palmitoyltransferase deficiency","volume":"Volume 2","author":"Engel","year":"1986","journal-title":"Myology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0887-8994(87)90056-7","article-title":"Carnitine palmityltransferase deficiency with permanent weakness","volume":"3","author":"Gieron","year":"1987","journal-title":"Pediatr. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1212\/01.WNL.0000055901.58642.48","article-title":"Carnitine palmitoyltransferase II deficiency: Molecular and biochemical analysis of 32 patients","volume":"60","author":"Wieser","year":"2003","journal-title":"Neurology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00415-006-0447-x","article-title":"Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations","volume":"254","author":"Deschauer","year":"2007","journal-title":"J. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.1225","article-title":"Molecular heterogeneity of myophosphorylase deficiency (McArdle\u2019s disease): A genotype-phenotype correlation study","volume":"50","author":"Rubio","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF01716746","article-title":"Acute rhabdomyolysis with carnitine-palmityl-transferase deficiency","volume":"8","author":"Blanc","year":"1982","journal-title":"Intensive Care Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of Estrogens in the Regulation of Liver Lipid Metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1073\/pnas.89.18.8429","article-title":"Molecular characterization of inherited carnitine palmitoyltransferase II deficiency","volume":"89","author":"Taroni","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1203\/00006450-198809000-00006","article-title":"Hepatic and Muscular Presentations of Carnitine Palmitoyl Transferase Deficiency: Two Distinct Entities","volume":"24","author":"Demaugre","year":"1988","journal-title":"Pediatr. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ng0793-314","article-title":"Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients","volume":"4","author":"Taroni","year":"1993","journal-title":"Nat. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1432-1033.1985.tb08913.x","article-title":"Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle","volume":"149","author":"Zierz","year":"1985","journal-title":"Eur. J. Biochem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2013.04.008","article-title":"Differences between acylcarnitine profiles in plasma and bloodspots","volume":"110","author":"Diekman","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10545-013-9666-3","article-title":"Muscle MRI in patients with long-chain fatty acid oxidation disorders","volume":"37","author":"Diekman","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nmd.2010.06.018","article-title":"Disorders of muscle lipid metabolism: Diagnostic and therapeutic challenges","volume":"20","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"ref_58","first-page":"351","article-title":"State of the art in muscle lipid diseases","volume":"29","author":"Liang","year":"2010","journal-title":"Acta Myol. Myopathies Cardiomyopathies Off. J. Mediterr. Soc. Myol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2014.02.011","article-title":"Normal protein content but abnormally inhibited enzyme activity in muscle carnitine palmitoyltransferase II deficiency","volume":"339","author":"Lehmann","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00415-013-6887-1","article-title":"Expanding mutation spectrum in CPT II gene: Identification of four novel mutations","volume":"260","author":"Joshi","year":"2013","journal-title":"J. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Lehmann, D., Motlagh, L., Robaa, D., and Zierz, S. (2017). Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18010082"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1212\/NXG.0000000000000053","article-title":"Stabilization of the thermolabile variant S113L of carnitine palmitoyltransferase II","volume":"2","author":"Motlagh","year":"2016","journal-title":"Neurol. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJM197502272920902","article-title":"A disorder of muscle lipid metabolism and myoglobinuria. Absence of carnitine palmityl transferase","volume":"292","author":"Bank","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/0003-4819-88-5-610","article-title":"Recurrent myoglobinuria due to muscle carnitine palmityl transferase deficiency","volume":"88","author":"Reza","year":"1978","journal-title":"Ann. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.31.7.883","article-title":"Carnitine palmityl transferase deficiency: Clinical variability, carrier detection, and autosomal-recessive inheritance","volume":"31","author":"Angelini","year":"1981","journal-title":"Neurology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM197803092981007","article-title":"Partial deficiency of muscle carnitine palmitoyltransferase with normal ketone production","volume":"298","author":"Hostetler","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jnnp.43.8.679","article-title":"Combined partial deficiency of muscle carnitine palmitoyltransferase and carnitine with autosomal dominant inheritance","volume":"43","author":"Ionasescu","year":"1980","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.30.6.627","article-title":"Partial deficiency of carnitine palmityltransferase: Physiologic and biochemical consequences","volume":"30","author":"Layzer","year":"1980","journal-title":"Neurology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0960-8966(92)90057-D","article-title":"Immunoquantitation of carnitine palmitoyl transferase in skeletal muscle of 31 patients","volume":"2","author":"Vladutiu","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471250953.bi0113s39","article-title":"The Human Gene Mutation Database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution","volume":"39","author":"Stenson","year":"2012","journal-title":"Curr. Protoc. Bioinforma."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbalip.2015.10.005","article-title":"Malony-CoA inhibits the S113L variant of carnitine-palmitoyltransferase II","volume":"1861","author":"Motlagh","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1023\/A:1025947930752","article-title":"Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency","volume":"26","author":"Olpin","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2174\/0929867325666180111094336","article-title":"FGF-21 as a Potential Biomarker for Mitochondrial Diseases","volume":"25","author":"Scholle","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10545-010-9222-3","article-title":"Biomarkers for mitochondrial respiratory chain disorders","volume":"34","author":"Suomalainen","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1210\/en.2009-0532","article-title":"Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis","volume":"150","author":"Badman","year":"2009","journal-title":"Endocrinology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.0000000000000578","article-title":"Serum FGF21 levels in adult m.3243A>G carriers: Clinical implications","volume":"83","author":"Koene","year":"2014","journal-title":"Neurology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.celrep.2016.04.057","article-title":"Impaired Mitochondrial Fat Oxidation Induces FGF21 in Muscle","volume":"15","author":"Vandanmagsar","year":"2016","journal-title":"Cell Rep."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Motlagh Scholle, L., Lehmann, D., Joshi, P.R., and Zierz, S. (2019). Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061400"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cmet.2017.07.007","article-title":"mTORC1 Regulates Mitochondrial Integrated Stress Response and Mitochondrial Myopathy Progression","volume":"26","author":"Khan","year":"2017","journal-title":"Cell Metab."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"18443","DOI":"10.1074\/jbc.M117.800839","article-title":"Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy","volume":"292","author":"Pereyra","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.celrep.2017.06.080","article-title":"Loss of Hepatic Mitochondrial Long-Chain Fatty Acid Oxidation Confers Resistance to Diet-Induced Obesity and Glucose Intolerance","volume":"20","author":"Lee","year":"2017","journal-title":"Cell Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.celrep.2016.05.062","article-title":"Hepatic Fatty Acid Oxidation Restrains Systemic Catabolism during Starvation","volume":"16","author":"Lee","year":"2016","journal-title":"Cell Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.celrep.2014.12.023","article-title":"Adipose fatty acid oxidation is required for thermogenesis and potentiates oxidative stress-induced inflammation","volume":"10","author":"Lee","year":"2015","journal-title":"Cell Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmet.2017.11.004","article-title":"Fatty acid oxidation is required for active and quiescent brown adipose tissue maintenance and thermogenic programing","volume":"7","author":"Lee","year":"2018","journal-title":"Mol. Metab."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1212\/01.wnl.0000436068.43384.ef","article-title":"Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease","volume":"81","author":"Davis","year":"2013","journal-title":"Neurology"},{"key":"ref_86","first-page":"600","article-title":"Myopathy in the course of carnitine palmitoyltransferase II deficiency","volume":"46","author":"Tomczykiewicz","year":"2012","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.braindev.2010.09.002","article-title":"Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases","volume":"33","author":"Shinohara","year":"2011","journal-title":"Brain Dev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0167-4781(96)00069-3","article-title":"Isolation and characterization of cDNA and genomic clones encoding human muscle type carnitine palmitoyltransferase I","volume":"1307","author":"Yamazaki","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1399-0004.2008.00986.x","article-title":"Mutations of carnitine palmitoyltransferase II (CPT II) in Japanese patients with CPT II deficiency","volume":"73","author":"Yasuno","year":"2008","journal-title":"Clin. Genet."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00508-012-0296-9","article-title":"Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency","volume":"124","author":"Joshi","year":"2012","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ajmg.a.20573","article-title":"Response to therapy in carnitine\/acylcarnitine translocase (CACT) deficiency due to a novel missense mutation","volume":"126","author":"Iacobazzi","year":"2004","journal-title":"Am. J. Med. Genet. A."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00000542-198806000-00021","article-title":"Postanesthetic acute renal failure due to carnitine palmityl transferase deficiency","volume":"68","author":"Katsuya","year":"1988","journal-title":"Anesthesiology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nmd.2008.03.007","article-title":"No carnitine palmitoyltransferase deficiency in skeletal muscle in 18 malignant hyperthermia susceptible individuals","volume":"18","author":"Wieser","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1212\/01.wnl.0000318283.42961.e9","article-title":"Carnitine palmitoyltransferase II deficiency: Successful anaplerotic diet therapy","volume":"71","author":"Roe","year":"2008","journal-title":"Neurology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1056\/NEJMc0806334","article-title":"Bezafibrate for an inborn mitochondrial beta-oxidation defect","volume":"360","author":"Bonnefont","year":"2009","journal-title":"N. Engl. J. Med."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/8\/1784\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:08:57Z","timestamp":1760364537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/8\/1784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,13]]},"references-count":95,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["molecules25081784"],"URL":"https:\/\/doi.org\/10.3390\/molecules25081784","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,13]]}}}